Issue · Healthcare

Healthcare (Substance Abuse)

Every healthcare bill, vote, and legislator stance in United States, automatically classified by Maddy, our AI policy reader.

Total bills
188
119th Congress
Top supporter
-
no data yet
Top opponent
-
no data yet
Ranked legislators
0
0 support · 0 oppose
Showing 1–10 of 188 bills

All healthcare bills

in committee · United States · House Sep 10, 2026

HRES 1528: Recognizing suicide as a serious public health problem and expressing support for the designation of September, 2026, as "National Suicide Prevention Month" as well as September 10, 2026, as "World Suicide Prevention Day".

This House resolution formally recognizes suicide as a serious public health problem in the United States and expresses support for designating September 2026 as National Suicide Prevention Month and September 10, 2026, as World Suicide Prevention Day. The bill cites data from the CDC, SAMHSA, and the VA to highlight that suicide is a leading cause of death among young people, veterans, and during the postpartum period, while also noting the significant economic costs associated with it. It declares suicide prevention a national priority and emphasizes that mental health is as important as physical health. The resolution supports the development of strategies to improve access to quality mental health, substance abuse, and suicide prevention services for all communities.
in committee · United States · Senate Aug 8, 2026

S 5383: End Gas Station Heroin Act

The End Gas Station Heroin Act adds two specific kratom compounds, 7-hydroxymitragynine and mitragynine pseudoindoxyl, to the federal list of Schedule I controlled substances. However, it includes an exemption for these compounds when they occur naturally in finished kratom products that meet strict concentration limits, while explicitly excluding synthetically produced or chemically concentrated versions from this protection. The bill also creates a new enforcement mechanism that treats any emerging synthetic opioid with greater potency than morphine as a Schedule I controlled substance if it is manufactured or distributed for commercial sale. This provision targets the production and distribution of these substances but explicitly prohibits criminal or civil penalties for simple possession or personal use by consumers.
in committee · United States · House Sep 3, 2026

HR 10254: MORE Savings Act

The MORE Savings Act aims to reduce financial barriers for individuals seeking treatment for opioid use disorders by eliminating out-of-pocket costs for specific services. For Medicare beneficiaries, it establishes a five-year pilot program in 15 selected states that removes coinsurance, copayments, and deductibles for prescription drugs, behavioral health care, and community recovery support. Additionally, the bill mandates that private group health plans and individual insurance policies cover these same opioid treatments without cost-sharing requirements starting in 2027. Finally, it increases the federal funding match to 90 percent for states providing medication-assisted treatment through Medicaid and allows states to include recovery support services in this coverage.
in committee · United States · House Aug 31, 2026

HRES 1503: Supporting the goals of Overdose Awareness Day and strengthening efforts to combat the opioid crisis in the United States.

This House resolution formally recognizes Overdose Awareness Day in the United States and calls for strengthened efforts to combat the opioid crisis. It directs the House of Representatives to pursue bipartisan legislation aimed at reducing the stigma associated with substance use disorders and drug overdoses. Additionally, the bill commits lawmakers to work with state and local governments, businesses, and health care providers to build a comprehensive system that supports prevention, treatment, harm reduction, and recovery for individuals affected by opioid use disorder.
Sub-Topics Substance Abuse
in committee · United States · Senate Aug 6, 2026

S 5305: Campus Lifeline Act

The Campus Lifeline Act expands federal grant programs to support student-led mental health and substance use disorder interventions at institutions of higher education. It authorizes funding for peer awareness activities, such as suicide prevention education and digital campaigns that encourage students to seek help, while requiring grantees to provide accessible resources for online and distance-learning students. Additionally, the bill directs the National Suicide Prevention Lifeline program to coordinate with schools and universities to list hotline numbers on student identification cards and promote behavioral health resources through public service announcements.
in committee · United States · Senate Aug 3, 2026

S 5207: RCORP Authorization Act

The RCORP Authorization Act establishes a new program to provide funding for preventing, treating, and recovering from opioid and other substance use disorders in rural areas. This program allows the Health Resources and Services Administration to award grants to states, tribal organizations, and other eligible entities for up to five years. The funds can be used for planning, implementing evidence-based treatment models, addressing emerging public health issues, and providing technical assistance, but they cannot be used to buy or improve real property. The legislation authorizes $165 million annually for each fiscal year from 2027 through 2031 to support these efforts.
in committee · United States · House Aug 3, 2026

HR 10037: Virtual-Based Opioid Treatment for Veterans Act

The Virtual-Based Opioid Treatment for Veterans Act directs the Department of Veterans Affairs to launch a two-year pilot program aimed at expanding access to virtual opioid treatment for enrolled veterans who face barriers to in-person care. This initiative requires the VA to conduct outreach, build referral networks, and coordinate with other federal agencies to connect veterans with telehealth programs that combine medication and counseling in a single visit. The bill also mandates a study on treatment barriers and requires annual reports to Congress on the program's progress until the opioid crisis is no longer considered a public health emergency.
in committee · United States · House Jul 16, 2026

HR 9759: Turn the Tide Act

The Turn the Tide Act primarily increases federal funding for substance use disorder treatment, prevention, and recovery services, directing billions of dollars to states, tribes, and local organizations for the years 2027 through 2030. Key provisions include expanding Medicaid coverage for mental health and behavioral health services, removing insurance barriers to medication-assisted treatment, and limiting cost-sharing requirements for opioid overdose reversal medications. The bill also establishes new grant programs to support recovery housing, train first responders, and assist law enforcement with mental health and wellness initiatives. Additionally, it targets funding toward states with the highest rates of drug overdose deaths and extends existing waivers to improve Medicaid delivery systems in those areas.
in committee · United States · House Jul 14, 2026

HR 9675: Expanding Opportunities for Recovery Act of 2026

The Expanding Opportunities for Recovery Act of 2026 directs federal funding to states to improve access to opioid addiction treatment for individuals who lack health insurance or face coverage barriers. These grants must be managed by state substance abuse agencies and used to provide evidence-based services, such as medication-assisted treatment, based on medical recommendations. The legislation explicitly limits grant funds to cover no more than 60 consecutive days of treatment per person and requires states to report data on treatment outcomes and usage. Additionally, the bill mandates that the federal government evaluate the program's effectiveness and share results publicly while offering technical assistance to participating states.
in committee · United States · House Jul 20, 2026

HR 9790: Modernizing Opioid Treatment Access Act 2.0 of 2026

The Modernizing Opioid Treatment Access Act 2.0 of 2026 allows specific addiction medicine specialists to prescribe methadone for opioid use disorder to be dispensed directly through pharmacies, rather than requiring patients to attend traditional treatment clinics. This change permits these qualified doctors to use telemedicine for patient care and requires that the methadone be in a liquid or dispersible tablet form. While the bill maintains existing clinic-based treatment options, it streamlines access by removing the need for pharmacies to obtain separate registrations to dispense the medication. The law also mandates that patients sign informed consent forms explaining how privacy rules differ between clinic and pharmacy settings, and it requires the Drug Enforcement Administration to report on the program's progress to Congress every year.
Showing 1 to 10 of 188 bills
1 2 3 19 Next